Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC. [electronic resource]
Producer: 20120213Description: 165-71 p. digitalISSN:- 1759-4820
- Antineoplastic Agents -- pharmacology
- Carcinoma, Papillary -- drug therapy
- Carcinoma, Renal Cell -- drug therapy
- Fatal Outcome
- Female
- Fumarate Hydratase -- deficiency
- Glycolysis -- drug effects
- Humans
- Kidney Neoplasms -- drug therapy
- Mechanistic Target of Rapamycin Complex 1
- Multiprotein Complexes
- Proteins -- antagonists & inhibitors
- TOR Serine-Threonine Kinases
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.